Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(33.3%)

Phase 2

2(33.3%)

Phase 3

1(16.7%)

N/A

1(16.7%)

6Total

Phase 1(2)

Phase 2(2)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02096302Not ApplicableCompleted

The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health

Role: collaborator

NCT01591343Phase 2Terminated

Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma

Role: collaborator

NCT01726933Phase 3Completed

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Role: collaborator

NCT01793350Phase 1Withdrawn

Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy

Role: collaborator

NCT01408602Phase 2Unknown

A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients

Role: collaborator

NCT00820417Phase 1Completed

Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

Role: lead

All 6 trials loaded